Clinical trial considerations: Why diversity matters…
February 15, 2024 | Diversity, Inclusion, clinical trials
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here’s why diversity matters…
Clinical trials are crucial for understanding diseases and developing new treatments. For trials to truly benefit everyone, diversity among participants is key. But why does diversity matter?
Accurate results – Everyone’s genes, environment and lifestyles are different. Which is why it’s important that participants from different locations, and with differing ways of living are included; it helps in understanding how different populations may respond to treatment.
Health equity – Achieving health equity involves addressing social, economic and environmental factors that impact health outcomes. The principle behind health equity is that everyone should have the same access to healthcare, regardless of their background, race, ethnicity or circumstances, giving them a fair opportunity to be as healthy as possible.
Builds trust – Having a diverse representation of people participating in clinical trials helps to boost trust between healthcare providers, researchers and communities.
Hopefully we can agree that diversity in clinical trials is vitally important! So how can we ensure individuals feel seen, heard and respected? Here are a few things we always keep in mind when developing clinical trial support materials:
- Patient engagement – It’s important to fully understand the patient population we are creating for. By meeting with real people, there is potential to learn more about barriers to participation and what we can do to overcome them. For patients from diverse communities, we also consider different perceptions, the use of language and how information is received and acted upon. In our experience, the best way to do this is to engage with patients and ask for their feedback at every step of the process.
- Removing barriers – Some people face significant barriers that prevent them from being able to participate in a trial. These could be not having access to a local treatment centre or no way to get to a treatment centre if there is one. Financial burdens may also prevent someone from being able to take time out of work to take part in a trial or having the money to get to and from study visits. Digitalising trials can help to overcome some of these barriers by allowing patients to receive treatment, tests and assessments at home. Want to know more about how we can support you in navigating new digital strategies for clinical trials? We wrote a blog on this very topic!
- Create materials that represent a wide range of people – We ensure that variations in race, culture, age, gender, ethnicity, sexuality, and ability within any given target audience are always represented. And we do this via visual style or imagery, the words we use and how we localise the content, as well as the format of materials:
- Imagery – It can be difficult to achieve representative diversity in the imagery we use when there is such a range of body types and skin tones across the world. However, difficult doesn’t mean impossible. We recommend using illustrations as stylistically, they are better able to convey diversity.
- Localisation – In many cases, there may not be a one-size-fits-all approach to achieving diverse representation. This is why we never consider development of a single material to be sufficient. Instead, support materials should always be localised for all countries the study is planned for.
This doesn’t just mean translating the content though. It’s essential to also account for cultural adaptations that may be needed. Such as, are there technical limitations in some of your target countries? Do regional differences mean that some content may not be relatable across the board?
For example, here is how we created alternative food-related content for Latin America versus a more typical Western diet:
Diversity in clinical trials matters. Making sure participants feel represented matters. And representing diversity in clinical trial materials definitely matters. If you would like help in making sure every individual involved in your trial feels seen and appreciated, let’s talk.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
New report now available: Integrating ‘patient first’ into medicine development
A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...
The digital prescription – enhancing the patient experience with technology
We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.
Compliance — a driving force for influencing public perceptions of the pharma industry?
How does compliance play into public perceptions of pharma and why is it important for improving public opinion?
Another year, another B!
Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.
Clinical trial considerations: Why supporting HCPs matters…
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.
Clinical trial considerations: Why diversity matters…
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...
Clinical trial considerations: Why digital matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Clinical trials explained: Why imagery matters…
Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...
Clinical trials explained: Why health literacy matters…
Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...